These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20055122)

  • 1. [Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice].
    Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Fujikawa K; Namba K; Otani T; Yamaguchi K
    Jpn J Antibiot; 2009 Oct; 62(5):452-9. PubMed ID: 20055122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Shinzato T; Doyle E; Edelstein MA
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Lehr KH; Ren J
    J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    Edelstein PH; Shinzato T; Edelstein MA
    J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
    Baltch AL; Smith RP; Ritz W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of legionellesis pneumonia verified by isolation of Legionella pneumophila serogroup 1 from bronchoalveolar lavage fluid treated with levofloxacine and tigecycline].
    Galstian GM; Drokov MIu; Katrysh SA; Kliasova GA; Giliazitdinova EA; Karpova TI; Marakusha BI; Tartakovskiĭ IS
    Ter Arkh; 2011; 83(7):61-5. PubMed ID: 21894754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
    Sato T; Tateda K; Kimura S; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
    Baltch AL; Smith RP; Ritz WJ; Franke MA; Michelsen PB
    J Antimicrob Chemother; 2000 Jul; 46(1):51-5. PubMed ID: 10882688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
    Edelstein PH; Hu B; Edelstein MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of ciprofloxacin-resistant Legionella pneumophila in a patient with severe pneumonia.
    Bruin JP; Koshkolda T; IJzerman EP; Lück C; Diederen BM; Den Boer JW; Mouton JW
    J Antimicrob Chemother; 2014 Oct; 69(10):2869-71. PubMed ID: 24898020
    [No Abstract]   [Full Text] [Related]  

  • 14. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.
    Bruin JP; Ijzerman EP; den Boer JW; Mouton JW; Diederen BM
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):103-8. PubMed ID: 22100012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila.
    Jonas D; Engels I; Friedhoff C; Spitzmüller B; Daschner FD; Frank U
    J Antimicrob Chemother; 2001 Feb; 47(2):147-52. PubMed ID: 11157897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of environmental
    Sreenath K; Chaudhry R; Vinayaraj EV; Thakur B
    Future Microbiol; 2019 May; 14():661-669. PubMed ID: 31148475
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
    Wilson RE; Hill RLR; Chalker VJ; Mentasti M; Ready D
    J Antimicrob Chemother; 2018 Oct; 73(10):2757-2761. PubMed ID: 30053025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
    Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A
    J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China.
    Jia X; Ren H; Nie X; Li Y; Li J; Qin T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel model of replicative Legionella pneumophila lung infection in DBA/2 mice].
    Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Namba K; Otani T; Yamaguchi K
    Jpn J Antibiot; 2009 Oct; 62(5):445-51. PubMed ID: 20055121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.